Objectives: The objectives of this study were to use Indian Health Service (IHS) data from electronic health records to analyze human immunodeficiency virus (HIV) diagnoses among American Indian/Alaska Natives (AI/ANs) and to identify current rates and trends that can support data-driven policy implementation and resource allocation for this population. Methods: We analyzed provider visit data from IHS to capture all AI/AN patients who met a definition of a new HIV diagnosis from 2005 through 2014 by using International Classification of Diseases, Ninth Revision, Clinical Modification codes. We calculated rates and trends of new HIV diagnoses by age, sex, region, and year per 100 000 AI/ANs in the IHS user population.
leading to an underestimation of the burden of disease. [3] [4] [5] [6] A large subset of the AI/AN population is served by the Indian Health Service (IHS), an integrated national health care delivery system of primarily rural clinics and hospitals. The IHS serves an estimated 2.2 million AI/ANs. Patients must document AI/AN status to be eligible for care in the IHS.
The objectives of this study were to examine the current rates, demographic characteristics, and annual trends of new HIV diagnoses among the AI/AN population using IHS data from electronic health records. To our knowledge, this is the first use of data from IHS electronic health records to generate estimated rates of new HIV diagnoses.
Methods
The IHS consists of 45 hospitals and more than 300 health centers in 34 US states, mainly primary care clinics in rural areas that are federally or tribally operated. In addition, the IHS provides contracted care at out-of-network health facilities when needed. Federal IHS and tribal facility electronic health records, as well as contract records, are aggregated at the national level and are maintained by the IHS National Patient Information Reporting System (NPIRS). 7 NPIRS includes all inpatient discharge and outpatient visit records for services to patients eligible for IHS health care. We obtained records from NPIRS to retrospectively analyze and estimate rates of new HIV diagnoses among AI/ANs during calendar years 2005 through 2014; this period allowed for comparison with the most recent national surveillance estimates. The NPIRS database contains information that allowed us to exclude people who had a previously recorded HIV diagnosis during calendar years 2001 through 2004 (n ¼ 706), which precluded counting these people as a new diagnosis during the study period.
We used International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes for HIV (ie, 042-044, V08, 079.53, or 795.71), which includes an indeterminate HIV test result to ensure a sensitive case definition. 8 We defined a new HIV diagnosis as the first occurrence of an HIV diagnostic code in NPIRS in any of up to 15 diagnoses on any hospitalization or outpatient visit record for an individual during the study period.
We analyzed new HIV diagnoses for the study period by age group, sex, region, and year of HIV diagnosis of the patient. The IHS is divided into 7 regions for analysis: Alaska; East (Alabama, Connecticut, Florida, Louisiana, Maine, Maryland, Massachusetts, Mississippi, New York, North Carolina, Rhode Island, and South Carolina); Northern Plains East (Iowa, Michigan, Minnesota, and Wisconsin); Northern Plains West (Montana, Nebraska, North Dakota, South Dakota, and Wyoming); Southern Plains (Kansas, Oklahoma, and Texas); Southwest (Arizona, Colorado, Nevada, New Mexico, and Utah); and West (California, Idaho, Oregon, and Washington State). The West region is excluded from the inpatient discharge data because of the absence of IHS-operated or tribally operated hospitals and the incompleteness of data on contract health services. We included all regions for the analysis of outpatient visits.
The presence of an opportunistic infection (Table 1) Mental disorder not otherwise specified 310. 9 Nonpsychotic brain syndrome not otherwise specified 323.9
Encephalitis not otherwise specified 331. 9 Cerebral degeneration not otherwise specified 341.9 CNS demyelination not otherwise specified 348. 3 Encephalopathy, not elsewhere classified 349.9 CNS disorder not otherwise specified 481
Pneumococcal pneumonia 482
Other bacterial pneumonia 485 Bronchopneumonia, organism not otherwise specified 486
Pneumonia, organism not otherwise specified 783. 2 Abnormal loss of weight and underweight 799. 4 Cachexia Abbreviations: CNS, central nervous system; HIV, human immunodeficiency virus; ICD-9-CM, International Classification of Diseases, Ninth Revision, Clinical Modification.
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We calculated rates of new HIV diagnoses per 100 000 AI/ANs in the IHS user population (hereinafter, AI/ANs) by reported characteristics. The IHS population (approximately 1.6 million people) comprises all registered AI/ANs who received IHS-funded health care at least once in the preceding 3 years. We used Poisson regression analysis to test for trends over time and to calculate rate ratios (RRs) and 95% confidence intervals (CIs) for comparisons between groups.
We considered P < .05 to be significant. We used SAS/STAT version 9.3 for all analyses. 10 
Results
Rates of new HIV diagnoses among AI/ANs were stable from 2010 through 2014; during the entire study period (2005-2014), the average annual rate of new HIV infections The P value for trend was calculated by using Poisson regression, with P < .05 considered significant. through 2014 (16.5 per 100 000 AI/ANs; test for trend over time P ¼ .11). Rates of new HIV infection increased significantly among males (P < .001); among those aged 15-19 (P < .001), 45-49 (P < .001), and 50-54 (P ¼ .012); and in the Southwest region (P ¼ .002) ( Table 3) . Rates of new HIV infection decreased significantly among adults aged 35-39 from 2010 through 2014 (P ¼ .043). Annual rates of new HIV diagnoses varied widely because of small numbers in some categories.
Discussion
The rates of new HIV diagnoses among the AI/ANs reported in our study using IHS data were nearly 2 times those seen in the national HIV surveillance report 1 produced by using data from the National HIV Surveillance System (NHSS). The NHSS uses census estimates of the US AI/AN population to calculate rates of new HIV infection; this study used the total population served by the IHS to calculate similar rates and, therefore, the two are not directly comparable, but are estimates of two overlapping but different populations. In addition, only confirmed HIV diagnoses are counted in NHSS data, whereas we also included diagnoses with indeterminate HIV test results in our analysis. Racial misclassification among AI/ANs is rare in the IHS because documentation of AI/AN status is required to determine patient eligibility. Therefore, from the point of view of racial misclassification, we consider IHS NPIRS data to be a more accurate representation of the AI/AN population.
Our study showed that the rate of new HIV diagnoses was highest among males and those aged 20-59. Males had higher rates of new HIV infection across nearly all demographic categories and during the entire study period than did females and accounted for most new diagnoses. The rate of new HIV diagnoses among males also increased during 2010 through 2014. Understanding this trend can assist in shaping policies that target AI/AN males with culturally appropriate prevention messages, use of the latest testing technology to detect diagnoses of acute HIV infection, and linkage to services (eg, pre-exposure prophylaxis).
We found that 1 in 5 AI/ANs had an opportunistic infection within 90 days before or after a new HIV diagnosis, a proxy for late diagnosis of HIV; conversely, although measured by using a different method, an estimated 39% of people in the general US population had an opportunistic infection within 90 days before or after a new HIV diagnosis, according to data from 1996-2005. 11 If our results represent earlier detection of HIV infection in the IHS, this may be partially attributable to wide adoption of routine HIV screening of adults and adolescents per national recommendations. 12 Of note, AI/ANs have significantly higher death rates from HIV than non-Hispanic white people. IHS data do not implicate late diagnosis as a contributing factor and may point to a need for research assessing other possible factors that contribute to this disparity, such as access to care or adherence to treatment. 13 Whether certain trends, such as relatively high rates of new HIV diagnoses in the Southwest compared with other regions, indicate increased case finding through screening or elevated incidence is unclear. According to internal IHS data, IHS facilities in the Southwest region have the highest HIV screening coverage among those aged 13-64 nationwide, which may increase the detection of previously undiagnosed HIV. The Southwest region of the IHS also has the highest burden of syphilis, 14 which is known to be correlated with HIV incidence.
Limitations
Our study had several limitations. First, new HIV diagnoses reflect a newly detected HIV infection in a user of the IHS network as defined by an ICD-9-CM code; however, patients could seek care outside of the IHS system, which would not be recorded in NPIRS. To the extent that this occurred, there is potential for undercounting or overcounting annual numbers within the IHS data due to misclassifying the initial date of HIV diagnosis. However, this limitation is shared with national CDC surveillance data, and there was no reason to assume bias in directionality (ie, both overcounting and undercounting may have an equal probability of occurrence). In addition, a new HIV diagnosis does not necessarily indicate recent infection; a person may have been infected for a long time before the disease was diagnosed, thereby limiting our ability to determine the incidence of new infection. IHS NPIRS data do not include laboratory results, so this study relied strictly on ICD-9-CM coding for a definition of new HIV diagnoses. This study used a sensitive definition of HIV by including indeterminate HIV test results that can be recorded with an ICD-9-CM code; although only 8% of new diagnoses in this study came from this code, this inclusion may have led to an overestimation of new HIV diagnoses.
Conclusions
We found that the rate of new HIV diagnoses, based on provider visit data among IHS users, was stable from 2010 through 2014. AI/ANs aged 20-54, particularly men, may benefit from increased HIV prevention and screening efforts. Our findings on HIV trends may help tribal, federal, and state health entities serving tribal nations better target efforts on HIV prevention, screening, and linkage to care among AI/ANs. Furthermore, our analysis suggests that the rates and numbers of new HIV diagnoses in the AI/AN population reported to national surveillance may be underestimated because of racial/ethnic misclassification.
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